Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Pilates for Sedentary Individuals

23 juin 2026 mis à jour par: Rommanee Rojasavastera, Mahidol University

Efficacy of Pilates on Core Stability and Physical Fitness Among Sedentary Individuals

The global rise in physical inactivity represents an escalating public health crisis, with the proportion of insufficiently active adults projected to reach 35% by 2030. Office workers are at the highest risk due to prolonged occupational sitting; a lifestyle factor heavily linked to various musculoskeletal disorders. While maintaining an upright posture relies on the synergistic coordination of deep core muscles, extended sitting disrupts this muscular balance, leading to chronic postural decay. Although Pilates is proven to improve core muscle thickness, enhance physical fitness, and alleviate low back pain, existing literature shows high variability in training durations (ranging from 6 to 16 weeks) and lacks definitive conclusions regarding its long-term, residual effects post-intervention. Consequently, it remains unclear whether the benefits of Pilates can be sustained once the structured training stops. Therefore, this study aimed to investigate the efficacy of Pilates on core stability and physical fitness among sedentary individuals, providing insights into sustainable exercise interventions.

Aperçu de l'étude

Statut

Pas encore de recrutement

Type d'étude

Interventionnel

Inscription (Estimé)

34

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Changwat Nakhon Pathom
      • Salaya, Changwat Nakhon Pathom, Thaïlande, 73170
        • Faculty of Physical Therapy, Mahidol University
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Aged between 18 and 59 years.
  • Had a Body Mass Index (BMI) of ≥ 23 kg/m2.
  • Engaged in sedentary activities (sitting) for more than 7 hours per day.
  • Passed the Physical Activity Readiness Questionnaire (PAR-Q) assessment.
  • Did not currently participate in any other exercise programs or physical activities during the study period.

Exclusion Criteria:

  • Had visual impairments that could not be corrected with corrective lenses or glasses.
  • Had a medical history of spinal or lower extremity surgery.
  • Had medical conditions or received medications that affected balance and gait, such as neurological diseases or benign paroxysmal positional vertigo (BPPV).
  • Pregnant during the study period.
  • Had severe pain in any part of the body (pain score ≥ 7/10).
  • Inability to follow the research procedures.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Experimental group
Participants in the experimental group participated in a Pilates exercise program.
The 1-hour Pilates exercise program was supervised by an instructor.
Comparateur actif: Control group
Participants in the control group participated in a walking exercise program.
The 1-hour walking exercise program was supervised by a physical therapist. Participants walked on a treadmill, where the speed was gradually increased to achieve a moderate intensity level, maintaining their heart rates within 64% to 70% of their maximum heart rate.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Muscle thickness
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
A handheld ultrasound device was used to measure trunk muscle thickness at rest and during contraction.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Muscle strength
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
A handheld dynamometer was used to measure trunk muscle strength. Participants were instructed to maintain a maximal voluntary contraction (MVC) for 5 seconds per trial, with a 30-second rest period between trials to minimize fatigue.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Muscle flexibility
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
The sit-and-reach test was used to measure lower back and hamstring flexibility. Participants completed static stretching for 5 minutes before assessment. During the assessment, participants sat with knees fully extended and feet hip-width apart against the sit-and-reach box. They then reached forward, using their fingertips to displace the sliding scale as far as possible in a single trial.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Muscle endurance
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
The McGill Core Endurance Test was used to measure trunk muscle endurance. Each test was conducted once, with the duration recorded using a digital stopwatch. Timing commenced once the participant achieved the standardized starting position and ceased when they could no longer maintain the required posture.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Proprioception
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Joint Repositioning Error (JRE) was measured under both eyes-open and eyes-closed conditions to assess proprioception. Participants began the assessment seated with their hips and knees flexed at 90°, feet positioned shoulder-width apart, and arms resting naturally at their sides. From this baseline, they were guided into a neutral reference position-defined by full trunk extension and a flat spinal alignment-which they were instructed to memorize. To facilitate measurement, a marker was placed at the first sacral vertebra (S1), and a laser pointer was fixed 50 cm away from this landmark. The testing procedure required participants to perform three cycles of trunk flexion and extension before attempting to return to the neutral reference position as accurately as possible. The JRE represented the distance between the laser beam's initial and final positions.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Balance
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
The Y-Balance Test (YBT) was used to measure dynamic balance. Participants were instructed to reach out and push the indicator as far as possible.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Posture
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Posture was measured using the Posture-analyzing and Virtual Reconstructing (PAViR) system, which utilized an RGB-D camera for skeletal reconstruction.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Pain level
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Pain location was identified through participant interviews, while pain intensity was quantified using a 0-10 Visual Analogue Scale (VAS).
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Health-Related Quality of Life
Délai: Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.
Health-Related Quality of Life was measured using the Thai version of the World Health Organization Quality of Life Brief (WHOQOL-BREF-THAI). This 26-item instrument assessed four core domains: physical health, psychological health, social relationships, and environment. Responses were scored on a Likert scale, with higher scores indicating better health status and overall QoL.
Baseline, at 4 weeks post-training, at 8 weeks post-training, at 2 weeks post-training cessation, and at 4 weeks post-training cessation.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 août 2026

Achèvement primaire (Estimé)

1 août 2027

Achèvement de l'étude (Estimé)

1 décembre 2027

Dates d'inscription aux études

Première soumission

18 juin 2026

Première soumission répondant aux critères de contrôle qualité

18 juin 2026

Première publication (Réel)

24 juin 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

26 juin 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

23 juin 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

OUI

Description du régime IPD

Research data will be shared in a de-identified format only; for instance, participant names will be replaced with codes, and faces will be blurred in all images.

Type d'informations de prise en charge du partage d'IPD

  • RSE

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner